Soriatane (acitretin), a new oral retinoid for severe psoriasis

November 1997

Roche is introducing Soriatane (acitretin), a new oral retinoid for severe psoriasis.

Soriatane is the active metabolite of Tegison (etretinate).

It's eliminated faster from the body. Tegison takes several YEARS to be eliminated...Soriatane takes only several MONTHS.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote